Peter K.F. Chiu, MD, PhD, FRCSEd, presented “Transperineal Prostate Biopsy Under Local Anesthesia: Systematic and MRI-Ultrasound Fusion Biopsy” for the Grand Rounds in Urology audience in February, 2020.
How to cite: Chiu, Peter K.F. “Transperineal Prostate Biopsy Under Local Anesthesia: Systematic and MRI-Ultrasound Fusion Biopsy” February, 2020. Accessed Nov 2024. https://grandroundsinurology.com/transperineal-prostate-biopsy-under-local-anaesthesia-systematic-and-mri-ultrasound-fusion-biopsy/
Transperineal Prostate Biopsy Under Local Anesthesia: Systematic and MRI-Ultrasound Fusion Biopsy – Summary:
Peter K.F. Chiu, MD, PhD, FRCSEd, Honorary Clinical Assistant Professor and Associate Consultant in the Division of Urology in the Department of Surgery at the Prince of Wales Hospital, Chinese University of Hong Kong, discusses the rationale and procedure for conducting transperineal prostate biopsies. He highlights how the decreased occurrence of sepsis makes transperineal biopsy a better choice than transrectal, in addition to a higher chance of obtaining cores and a reduced chance of deformation from the TRUS probe. Dr. Chiu also details the administration of local anesthesia, and illustrates successful procedures for both systematic and MRI-ultrasound fusion approaches to obtaining prostate biopsy cores.
ABOUT THE AUTHOR
Peter K. F. Chiu, MBChB, PhD (Erasmus), FRCSEd (Urol), graduated from the Faculty of Medicine of the Chinese University of Hong Kong (CUHK) and obtained a fellowship in urology from the College of Surgeons of Edinburgh. He received post-graduate training in prostate cancer research and andrology in the Erasmus Medical Centre in Rotterdam, The Netherlands, and obtained a PhD degree in prostate cancer diagnosis. Dr. Chiu is an Associate Professor in the Division of Urology in CUHK. He is the current President of the Hong Kong Urological Association (HKUA).
Dr. Chiu’s clinical practice and research focus is on prostate cancer, including prostate cancer screening, diagnosis with novel biomarkers (prostate health index, urine spermine), MRI-guided targeted prostate biopsy, and focal therapy. He utilizes HIFU, Cryotherapy, and Targeted microwave ablation (TMA) as focal therapy for prostate cancer. He also has special interest in managing patients with advanced prostate cancer with novel treatment options.
Dr. Chiu is a member of the prostate cancer working group of the European Association of Urology (EAU) Young Academic Urologists, and a council member of the Société Internationale d'Urologie (SIU) Academic Research Council and SIU Scientific Program Committee. He is a board member of the Hong Kong Kidney Foundation and editorial board member of the Asian Journal of Andrology and the International Journal of Urology. Dr. Chiu is also an associate editor for Frontiers in Surgery (Genitourinary Surgery) and Grand Rounds in Urology.
